SlideShare a Scribd company logo
Page 1
Measure Suggested Documentation
Suggested Documentation
For Exclusions
EPOM 01
Protect Patient
Health
Information
A security risk analysis of the EP's Certified Electronic Health Record Technology (CEHRT)
system, which was performed no earlier than the start of the reporting year and no later than the
date of attestation (i.e. a report which documents the procedures performed during the analysis and
the results of the analysis). This analysis must be in accordance with the requirements under 45
CFR 164.308(a) (1), including addressing the encryption/security of data stored in CEHRT in
accordance with requirements under 45 CFR 164.312 (a)(2)(iv) and 45 CFR 164.306(d)(3). The
testing could occur prior to the beginning of the first EHR reporting period. However, a new review
would have to occur for each subsequent reporting period. Documentation should also be supplied
to show that the EP implemented security updates as necessary and corrected identified security
deficiencies.
There is no exclusion for this measure.
EPOM 02
Clinical Decision
Support
For Measure #1- Documentation which proves that five clinical decision support interventions
exist in the EP's CEHRT system (i.e. audit trail, screenshots from the system, letter/e-mail from the
vendor, etc.) and that they remained active throughout the EP's reporting period (i.e. a schedule of
alerts related to clinical decision support interventions that fired during the reporting period or an
indication that the interventions can not be turned off).
For Alternate Measure #1 - Documentation which proves that a clinical decision support rule
exists in the EP's CEHRT system (i.e. audit trail, screenshots from the system, letter/e-mail from
the vendor, etc.) and that it remained active throughout the EP's reporting period (i.e. a schedule of
alerts related to a clinical decision support rule that fired during the reporting period or an
indication that the rule can not be turned off).
For Measure #2- Documentation which proves that this functionality is available in the EP's EHR
system (i.e. audit trail, screenshots from the system, letter/e-mail from the vendor, etc.) and that it
remained active throughout the EP's reporting period (i.e. a schedule of alerts that fired during the
reporting period or an indication that the feature can not be turned off).
There is no exclusion for the first measure.
To meet the exclusion for the second measure, the EP is required to write fewer than 100 medication orders during the EHR reporting
period. To support this exclusion, provide the following:
A summary report, preferably generated by the EP's Certified Electronic Health Record Technology system. This report should
include the following:
● Denominator for Objective Measure #3 (Medication) which should be < 100
● Time period which it covers
● Name of the EP
EPOM 03
CPOE for
Medication,
Laboratory,
and Radiology
Orders
A summary report, preferably generated by the EP's Certified Electronic Health Record Technology
(CEHRT) system. This report should include the following:
● Numerators and denominators for all three CPOEs
● Time period which it covers (must cover the attestation period)
● Name of the EP
If possible, evidence demonstrating that this report was generated by the CEHRT system (i.e. a
screenshot of the report before it has been printed from the system).
A summary report, preferably generated by the EP's Certified Electronic Health Record Technology system. This report should
include the following:
● Denominators for this measure, which should be < 100 (should be 3 sets of numerators & denominators: Medication, Laboratory,
Radiology)
● Time period which it covers (must cover the attestation period)
● Name of the EP
Note- These exclusions are independent of each other. For example, an EP can be excluded from the medication order measure, but
be required to report the laboratory and radiology order measures, based on the threshold of writing 100 orders.
Alternate Exclusion for Measure 2 : Providers scheduled to be in Stage 1 in 2015 may claim an exclusion for measure 2 (laboratory
orders) of the Stage 2 CPOE objective for an EHR reporting period in 2015.
Alternate Exclusion for Measure 3 : Providers scheduled to be in Stage 1 in 2015 may claim an exclusion for measure 3 (radiology
orders) of the Stage 2 CPOE objective for an EHR reporting period in 2015.
Eligible Professionals- Objective Measures
Page 2
Measure Suggested Documentation
Suggested Documentation
For Exclusions
Eligible Professionals- Objective Measures
EPOM 04
Electronic
Prescribing
(eRx)
A summary report, preferably generated by the EP's Certified Electronic Health Record Technology
(CEHRT) system. This report should include the following:
● Numerator and denominator for this measure
● Time period which it covers (must cover the attestation period)
● Name of the EP
If possible, evidence demonstrating that this report was generated by the CEHRT system (i.e. a
screenshot of the report before it has been printed from the system).
One of the following exclusions must be documented:
Exclusion #1A- A summary report, preferably generated by the EP's CEHRT system. This report should include the following:
● Denominator, which must be < 100
● Time period which it covers (must cover the attestation period)
● Name of the EP
Exclusion #1B- A statement indicating that at the start of the EHR reporting period, the EP did not have a pharmacy within their
organization or within 10 miles of their practice that accepted electronic prescriptions.
EPOM 05
Health
Information
Exchange
A summary report, preferably generated by the EP's Certified Electronic Health Record Technology
(CEHRT) system. This report should include the following:
● Numerator and denominator for this measure
● Time period which it covers (must cover the attestation period)
● Name of the EP
If possible, evidence demonstrating that this report was generated by the CEHRT system (i.e. a
screenshot of the report before it has been printed from the system).
A summary report, preferably generated by the EP's Certified Electronic Health Record Technology system. This report should
include the following:
● Denominator for this measure which should be < 100
● Time period which it covers
● Name of the EP
Alternate Exclusion : Providers may claim an exclusion for the Stage 2 measure that requires the electronic transmission of a
summary of care document if for an EHR reporting period in 2015, they were scheduled to demonstrate Stage 1, which does not have
an equivalent measure.
EPOM 06
Patient-Specific
Education
A summary report, preferably generated by the EP's Certified Electronic Health Record Technology
(CEHRT) system. This report should include the following:
● Numerator and denominator for this measure
● Time period which it covers (must cover the attestation period)
● Name of the EP
If possible, evidence demonstrating that this report was generated by the CEHRT system (i.e. a
screenshot of the report before it has been printed from the system).
A summary report, preferably generated by the EP's Certified Electronic Health Record Technology system. This report should
include the following:
● Denominator for this measure which should be zero
● Time period which it covers (must cover the attestation period)
● Name of the EP
Alternate Exclusion : Provider may claim an exclusion for the measure of the Stage 2 Patient Specific Education objective if for an
EHR reporting period in 2015 they were scheduled to demonstrate Stage 1 but did not intend to select the Stage 1 Patient Specific
Education menu objective.
EPOM 07
Medication
Reconciliation
A summary report, preferably generated by the EP's Certified Electronic Health Record Technology
(CEHRT) system. This report should include the following:
● Numerator and denominator for this measure
● Time period which it covers (must cover the attestation period)
● Name of the EP
If possible, evidence demonstrating that this report was generated by the CEHRT system (i.e. a
screenshot of the report before it has been printed from the system).
A summary report, preferably generated by the EP's Certified Electronic Health Record Technology system. This report should
include the following:
● Denominator for this measure which should be zero
● Time period which it covers (must cover the attestation period)
● Name of the EP
Alternate Exclusion : Provider may claim an exclusion for the measure of the Stage 2 Medication Reconciliation objective if for an
EHR reporting period in 2015 they were scheduled to demonstrate Stage 1 but did not intend to select the Stage 1 Medication
Reconciliation menu objective.
Page 3
Measure Suggested Documentation
Suggested Documentation
For Exclusions
Eligible Professionals- Objective Measures
EPOM 08
Patient
Electronic
Access
A summary report, preferably generated by the EP's Certified Electronic Health Record Technology
(CEHRT) system. This report should include the following:
● Numerator and denominator for this measure (for both measure #1 & 2)
● Time period which it covers (must cover the attestation period)
● Name of the EP
If possible, evidence demonstrating that this report was generated by the CEHRT system (i.e. a
screenshot of the report before it has been printed from the system).
There is no exclusion for the first measure.
Exclusions for the second measure:
Exclusion #1A- A statement indicating why the EP does not order or create any of the information listed for inclusion as part of the
measure (patient name, provider's name and office contact information, current and past problem list, procedures, laboratory test
results, current medication list and medication history, current medication allergy list and medication allergy history, vital signs,
smoking status, demographic information, care plan fields, and any known care team members including the primary care provider
(PCP) of record) except for "Patient name" and "Provider's name and office contact information". (Excludes second measure only)
Exclusion #1B- A statement identifying the county and zip code where the EP conducts ≥ 50% of his/her patient encounters.
(Excludes second measure only)
Alternate Exclusion Measure #2- Providers may claim an exclusion for the second measure if for an EHR reporting period in 2015
they were scheduled to demonstrate Stage 1, which does not have an equivalent measure.
EPOM 09
Secure
Electronic
Messaging
Documentation which proves that this capability was fully enabled in the EP's EHR system (i.e.
audit trail, screenshots from the system, letter/e-mail from the vendor, etc.) and that it remained
active throughout the EP's reporting period (i.e. a schedule of alerts that fired during the reporting
period or an indication that the feature can not be turned off).
One of the following exclusions must be documented:
Exclusion #1A- A summary report, generated by the EP's Certified Electronic Health Record Technology system. This report should
include the following:
● Denominator for Measure #6 (Patient-Specific Education) which should be zero
● Time period which it covers (must cover the attestation period)
● Name of the EP
Exclusion #1B- A statement identifying the county and zip code where the EP conducts ≥ 50% of his/her patient encounters.
Alternate Exclusion- An EP may claim an exclusion for the measure if for an EHR reporting period in 2015 they were scheduled to
demonstrate Stage 1, which does not have an equivalent measure.
Page 4
Measure Suggested Documentation
Suggested Documentation
For Exclusions
Eligible Professionals- Objective Measures
EPOM 10
Public Health
Reporting
One of the following criteria must be documented for each attested to measure:
For Active Engagement Option (1), documentation from the EP's public health agency (letter, e-
mail, website screenshot, etc.) demonstrating the EP registered to submit data with the PHA or,
where applicable, the CDR to which the information is being submitted; registration was
completed within 60 days after the start of the EHR reporting period; and the EP is awaiting an
invitation from the PHA or CDR to begin testing and validation. An example of acceptable
documentation would be a letter or e-mail from the public health agency confirming the date the EP
registered to submit data with the PHA or, where applicable, the CDR to which the information is
being submitted and that the EP is awaiting an invitation from the PHA or CDR to begin testing
and validation.
For Active Engagement Option (2), documentation from the EP's public health agency (letter, e-
mail, website screenshot, etc.) demonstrating that the EP is in the process of testing and validation
of the electronic submission of data. Providers must respond to requests from the PHA or, where
applicable, the CDR within 30 days; failure to respond twice within an EHR reporting period
would result in that provider not meeting the measure. An example of acceptable documentation
would be a letter or e-mail from the public health agency confirming that the EP is in the process of
testing and validation of the electronic submission of data.
For Active Engagement Option (3), documentation from the EP's public health agency (letter, e-
mail, website screenshot, etc.) demonstrating that the EP has completed testing and validation of
the electronic submission and is electronically submitting production data to the PHA or CDR. An
example of acceptable documentation would be a letter or e-mail from the public health agency
confirming that the EP has completed testing and validation of the electronic submission and is
electronically submitting production data to the PHA or CDR.
One of the following exclusions must be documented:
Exclusion #1-
Measure #1 - A statement from the EP detailing what types of immunizations, if any, they administered during the reporting period.
If the EP administers immunizations that are not being collected by the registry, obtain confirmation from the registry.
Measure #2 - A statement from the EP indicating why they are not in a category of providers that collects ambulatory syndromic
surveillance information.
Measure #3 - A statement from the EP explaining why they do not diagnose or directly treat any disease associated with a specialized
registry or the public health agencies in their jurisdiction.
Exclusion #2-
Measure #1 - Documentation from the EP's immunization registry or immunization information system (letter, e-mail, website
screenshot, etc.) stating that they were not capable of accepting the specific standards required to meet the CEHRT definition at the
start of the EHR reporting period.
Measure #2 - Documentation from the EP's public health agency (letter, e-mail, website screenshot, etc.) stating that they were not
capable of receiving electronic syndromic surveillance data from EPs in the specific standards required to meet the CEHRT
definition at the start of the EHR reporting period.
Measure #3 - Documentation from the EP's specialized registry (letter, e-mail, website screenshot, etc.) stating that they were not
capable of accepting electronic registry transactions in the specific standards required to meet the CEHRT definition at the start of the
EHR reporting period.
Exclusion #3-
Measure #1 - Documentation from the EP's immunization registry or immunization information system (letter, e-mail, website
screenshot, etc.) which demonstrates that EP operates in a jurisdiction where no immunization registry or immunization information
system has declared readiness to receive immunization data from the EP at the start of the EHR reporting period.
Measure #2 - Documentation from the EP's public health agency (letter, e-mail, website screenshot, etc.) which demonstrates that EP
operates in a jurisdiction where no public health agency has declared readiness to receive syndromic surveillance data from EPs at
the start of the EHR reporting period.
Measure #3 - Documentation from the EP's specialized registry (letter, e-mail, website screenshot, etc.) which demonstrates that EP
operates in a jurisdiction where no specialized registry for which the EP is eligible has declared readiness to receive electronic
registry transactions at the beginning of the EHR reporting period.
Alternate Exclusion - EPs scheduled to be in Stage 1 must attest to at least 1 measure from the Public Health Reporting Objective
Measures 1-3.
• May claim an Alternate Exclusion for Measure 1, Measure 2, or Measure 3.
• An Alternate Exclusion may only be claimed for up to two measures, then the provider must either attest to or meet the exclusion
requirements for the remaining measure described in 495.22 (e)(10)(i).

More Related Content

What's hot

MHRA - 18th March 2014
MHRA - 18th March 2014MHRA - 18th March 2014
MHRA - 18th March 2014
Anthony A Hill
 
Online Clinical Trial Notification (CTN)
Online Clinical Trial Notification (CTN)Online Clinical Trial Notification (CTN)
Online Clinical Trial Notification (CTN)
TGA Australia
 
PSUR Requirements
PSUR RequirementsPSUR Requirements
Development safety update report (dsur) pharmacovigilance and safety
Development safety update report (dsur)   pharmacovigilance and safetyDevelopment safety update report (dsur)   pharmacovigilance and safety
Development safety update report (dsur) pharmacovigilance and safety
Azierta
 
RMP_14th Annual Conference of Society of Pharmacovigilance and International ...
RMP_14th Annual Conference of Society of Pharmacovigilance and International ...RMP_14th Annual Conference of Society of Pharmacovigilance and International ...
RMP_14th Annual Conference of Society of Pharmacovigilance and International ...
Dr Vineet Shastri
 
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
TGA Australia
 
Periodic safety update reports – gvp guidelines and changes
Periodic safety update reports – gvp guidelines and changesPeriodic safety update reports – gvp guidelines and changes
Periodic safety update reports – gvp guidelines and changes
Turacoz Healthcare Solutions
 
PSUR
PSURPSUR
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Australia
 
ISO: 14971 Quality risk management of medical devices
ISO: 14971 Quality risk management  of medical devicesISO: 14971 Quality risk management  of medical devices
ISO: 14971 Quality risk management of medical devices
Atul Bhombe
 
Professor Peivand Pirouzi Inc. - Pharmacovigilance Inspections: Representati...
Professor Peivand Pirouzi Inc. - Pharmacovigilance Inspections: Representati...Professor Peivand Pirouzi Inc. - Pharmacovigilance Inspections: Representati...
Professor Peivand Pirouzi Inc. - Pharmacovigilance Inspections: Representati...
Pharmaceutical Compliance Inspection unit, Crown College of Canada
 
CER - PMS - PMCF
CER - PMS - PMCFCER - PMS - PMCF
CER - PMS - PMCF
Katarzyna Zofia Chrusciel
 
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA Australia
 
Presentation: CMA Advertising Seminar
Presentation: CMA Advertising SeminarPresentation: CMA Advertising Seminar
Presentation: CMA Advertising Seminar
TGA Australia
 
Turacoz - Risk Management Plan ( Regulatory Writing )
Turacoz - Risk Management Plan ( Regulatory Writing ) Turacoz - Risk Management Plan ( Regulatory Writing )
Turacoz - Risk Management Plan ( Regulatory Writing )
Turacoz Healthcare Solutions
 
TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...
TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...
TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...
TGA Australia
 
Data Integrity II - Chromatography data system (CDS) in Pharma
Data Integrity II - Chromatography data system (CDS) in PharmaData Integrity II - Chromatography data system (CDS) in Pharma
Data Integrity II - Chromatography data system (CDS) in Pharma
Sathish Vemula
 
Presentation: Risk Management Plan compliance monitoring
Presentation: Risk Management Plan compliance monitoringPresentation: Risk Management Plan compliance monitoring
Presentation: Risk Management Plan compliance monitoring
TGA Australia
 
Exploring information exchange opportunities between Industry and the TGA
Exploring information exchange opportunities between Industry and the TGAExploring information exchange opportunities between Industry and the TGA
Exploring information exchange opportunities between Industry and the TGA
TGA Australia
 
freipresleyecqmsnurse16
freipresleyecqmsnurse16freipresleyecqmsnurse16
freipresleyecqmsnurse16
Bill Presley
 

What's hot (20)

MHRA - 18th March 2014
MHRA - 18th March 2014MHRA - 18th March 2014
MHRA - 18th March 2014
 
Online Clinical Trial Notification (CTN)
Online Clinical Trial Notification (CTN)Online Clinical Trial Notification (CTN)
Online Clinical Trial Notification (CTN)
 
PSUR Requirements
PSUR RequirementsPSUR Requirements
PSUR Requirements
 
Development safety update report (dsur) pharmacovigilance and safety
Development safety update report (dsur)   pharmacovigilance and safetyDevelopment safety update report (dsur)   pharmacovigilance and safety
Development safety update report (dsur) pharmacovigilance and safety
 
RMP_14th Annual Conference of Society of Pharmacovigilance and International ...
RMP_14th Annual Conference of Society of Pharmacovigilance and International ...RMP_14th Annual Conference of Society of Pharmacovigilance and International ...
RMP_14th Annual Conference of Society of Pharmacovigilance and International ...
 
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
Presentation: Proposed Reforms to the Regulation of Software, Including Softw...
 
Periodic safety update reports – gvp guidelines and changes
Periodic safety update reports – gvp guidelines and changesPeriodic safety update reports – gvp guidelines and changes
Periodic safety update reports – gvp guidelines and changes
 
PSUR
PSURPSUR
PSUR
 
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
TGA Presentation: Therapeutic Goods Advertising Code (No. 2) 2018
 
ISO: 14971 Quality risk management of medical devices
ISO: 14971 Quality risk management  of medical devicesISO: 14971 Quality risk management  of medical devices
ISO: 14971 Quality risk management of medical devices
 
Professor Peivand Pirouzi Inc. - Pharmacovigilance Inspections: Representati...
Professor Peivand Pirouzi Inc. - Pharmacovigilance Inspections: Representati...Professor Peivand Pirouzi Inc. - Pharmacovigilance Inspections: Representati...
Professor Peivand Pirouzi Inc. - Pharmacovigilance Inspections: Representati...
 
CER - PMS - PMCF
CER - PMS - PMCFCER - PMS - PMCF
CER - PMS - PMCF
 
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
TGA webinar: The Good Manufacturing Practice (GMP) Clearance Framework – an o...
 
Presentation: CMA Advertising Seminar
Presentation: CMA Advertising SeminarPresentation: CMA Advertising Seminar
Presentation: CMA Advertising Seminar
 
Turacoz - Risk Management Plan ( Regulatory Writing )
Turacoz - Risk Management Plan ( Regulatory Writing ) Turacoz - Risk Management Plan ( Regulatory Writing )
Turacoz - Risk Management Plan ( Regulatory Writing )
 
TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...
TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...
TGA Presentation: TGA focus and wrap up - What we've done, and what we still ...
 
Data Integrity II - Chromatography data system (CDS) in Pharma
Data Integrity II - Chromatography data system (CDS) in PharmaData Integrity II - Chromatography data system (CDS) in Pharma
Data Integrity II - Chromatography data system (CDS) in Pharma
 
Presentation: Risk Management Plan compliance monitoring
Presentation: Risk Management Plan compliance monitoringPresentation: Risk Management Plan compliance monitoring
Presentation: Risk Management Plan compliance monitoring
 
Exploring information exchange opportunities between Industry and the TGA
Exploring information exchange opportunities between Industry and the TGAExploring information exchange opportunities between Industry and the TGA
Exploring information exchange opportunities between Industry and the TGA
 
freipresleyecqmsnurse16
freipresleyecqmsnurse16freipresleyecqmsnurse16
freipresleyecqmsnurse16
 

Similar to Prepayment Audit Suggested Documentation

Meaningful Use Workgroup Recommendations
Meaningful Use Workgroup Recommendations Meaningful Use Workgroup Recommendations
Meaningful Use Workgroup Recommendations
Brian Ahier
 
3.J Pharma monitoring of HVAC systems.docx
3.J Pharma monitoring of HVAC systems.docx3.J Pharma monitoring of HVAC systems.docx
3.J Pharma monitoring of HVAC systems.docx
SamehMostafa33
 
PQRI Coding Guidance 2007
PQRI Coding Guidance 2007PQRI Coding Guidance 2007
PQRI Coding Guidance 2007
e-MedTools
 
Introduction to changes to the TGA's Clinical Trial Notification (CTN) process
Introduction to changes to the TGA's Clinical Trial Notification (CTN) processIntroduction to changes to the TGA's Clinical Trial Notification (CTN) process
Introduction to changes to the TGA's Clinical Trial Notification (CTN) process
TGA Australia
 
Meaningful Use Stage 2 Kickoff
Meaningful Use Stage 2 KickoffMeaningful Use Stage 2 Kickoff
Meaningful Use Stage 2 Kickoff
Practice Fusion
 
P4-40 (ALL WORK MUST BE ON A EXCEL FILE)Completing the account.docx
P4-40 (ALL WORK MUST BE ON A EXCEL FILE)Completing the account.docxP4-40 (ALL WORK MUST BE ON A EXCEL FILE)Completing the account.docx
P4-40 (ALL WORK MUST BE ON A EXCEL FILE)Completing the account.docx
gerardkortney
 
Get Prepared and Find Success with Meaningful Use Stage 2 and 3
Get Prepared and Find Success with Meaningful Use Stage 2 and 3Get Prepared and Find Success with Meaningful Use Stage 2 and 3
Get Prepared and Find Success with Meaningful Use Stage 2 and 3
Iatric Systems
 
Webinar 4 : Achieve Meaningful Use Core Measures & Menu Measures using DigiDM...
Webinar 4 : Achieve Meaningful Use Core Measures & Menu Measures using DigiDM...Webinar 4 : Achieve Meaningful Use Core Measures & Menu Measures using DigiDM...
Webinar 4 : Achieve Meaningful Use Core Measures & Menu Measures using DigiDM...
Sagar Shah
 
2011 CMS Physician Quality Reporting System - Tony Hamm
2011 CMS Physician Quality Reporting System - Tony Hamm2011 CMS Physician Quality Reporting System - Tony Hamm
2011 CMS Physician Quality Reporting System - Tony Hamm
National University of Health Sciences
 
Meaningful Use Updates Webinar Slidedeck
Meaningful Use Updates Webinar SlidedeckMeaningful Use Updates Webinar Slidedeck
Meaningful Use Updates Webinar Slidedeck
Kimberly Hilton
 
Health IT Summit Austin 2013 - Keynote Presentation "Meaningful Use Stage 2 a...
Health IT Summit Austin 2013 - Keynote Presentation "Meaningful Use Stage 2 a...Health IT Summit Austin 2013 - Keynote Presentation "Meaningful Use Stage 2 a...
Health IT Summit Austin 2013 - Keynote Presentation "Meaningful Use Stage 2 a...
Health IT Conference – iHT2
 
Post analytical variables dr kamlesh patel
Post analytical variables dr kamlesh patelPost analytical variables dr kamlesh patel
Post analytical variables dr kamlesh patel
www.jaailab.com
 
Meaningful use stage 2 - Final Rule
Meaningful use stage 2 - Final RuleMeaningful use stage 2 - Final Rule
Meaningful use stage 2 - Final Rule
ZH Healthcare
 
Q&A về quy định quản lý hệ thống vi tính theo tiêu chuẩn GMP EU
Q&A về quy định quản lý hệ thống vi tính theo tiêu chuẩn GMP EUQ&A về quy định quản lý hệ thống vi tính theo tiêu chuẩn GMP EU
Q&A về quy định quản lý hệ thống vi tính theo tiêu chuẩn GMP EU
Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
Calibration of master plan
Calibration of master planCalibration of master plan
Calibration of master plan
DhanshreeBhattad
 
Hospital erp system
Hospital erp systemHospital erp system
Hospital erp system
Asma queen
 
How to get Prepared and Find Success with Meaningful Use Stage 2 and 3
How to get Prepared and Find Success with Meaningful Use Stage 2 and 3How to get Prepared and Find Success with Meaningful Use Stage 2 and 3
How to get Prepared and Find Success with Meaningful Use Stage 2 and 3
Iatric Systems
 
MU - PQRS presentation
MU - PQRS  presentationMU - PQRS  presentation
MU - PQRS presentation
Marcia Fastag
 
Quy định về quản lý hệ thống vi tính theo tiêu chuẩn GMP Nhật Bản
Quy định về quản lý hệ thống vi tính theo tiêu chuẩn GMP Nhật BảnQuy định về quản lý hệ thống vi tính theo tiêu chuẩn GMP Nhật Bản
Quy định về quản lý hệ thống vi tính theo tiêu chuẩn GMP Nhật Bản
Công ty Cổ phần Tư vấn Thiết kế GMP EU
 
OrHIMA Meaningful Use Stage 2 Presentation
OrHIMA Meaningful Use Stage 2 PresentationOrHIMA Meaningful Use Stage 2 Presentation
OrHIMA Meaningful Use Stage 2 Presentation
Brian Ahier
 

Similar to Prepayment Audit Suggested Documentation (20)

Meaningful Use Workgroup Recommendations
Meaningful Use Workgroup Recommendations Meaningful Use Workgroup Recommendations
Meaningful Use Workgroup Recommendations
 
3.J Pharma monitoring of HVAC systems.docx
3.J Pharma monitoring of HVAC systems.docx3.J Pharma monitoring of HVAC systems.docx
3.J Pharma monitoring of HVAC systems.docx
 
PQRI Coding Guidance 2007
PQRI Coding Guidance 2007PQRI Coding Guidance 2007
PQRI Coding Guidance 2007
 
Introduction to changes to the TGA's Clinical Trial Notification (CTN) process
Introduction to changes to the TGA's Clinical Trial Notification (CTN) processIntroduction to changes to the TGA's Clinical Trial Notification (CTN) process
Introduction to changes to the TGA's Clinical Trial Notification (CTN) process
 
Meaningful Use Stage 2 Kickoff
Meaningful Use Stage 2 KickoffMeaningful Use Stage 2 Kickoff
Meaningful Use Stage 2 Kickoff
 
P4-40 (ALL WORK MUST BE ON A EXCEL FILE)Completing the account.docx
P4-40 (ALL WORK MUST BE ON A EXCEL FILE)Completing the account.docxP4-40 (ALL WORK MUST BE ON A EXCEL FILE)Completing the account.docx
P4-40 (ALL WORK MUST BE ON A EXCEL FILE)Completing the account.docx
 
Get Prepared and Find Success with Meaningful Use Stage 2 and 3
Get Prepared and Find Success with Meaningful Use Stage 2 and 3Get Prepared and Find Success with Meaningful Use Stage 2 and 3
Get Prepared and Find Success with Meaningful Use Stage 2 and 3
 
Webinar 4 : Achieve Meaningful Use Core Measures & Menu Measures using DigiDM...
Webinar 4 : Achieve Meaningful Use Core Measures & Menu Measures using DigiDM...Webinar 4 : Achieve Meaningful Use Core Measures & Menu Measures using DigiDM...
Webinar 4 : Achieve Meaningful Use Core Measures & Menu Measures using DigiDM...
 
2011 CMS Physician Quality Reporting System - Tony Hamm
2011 CMS Physician Quality Reporting System - Tony Hamm2011 CMS Physician Quality Reporting System - Tony Hamm
2011 CMS Physician Quality Reporting System - Tony Hamm
 
Meaningful Use Updates Webinar Slidedeck
Meaningful Use Updates Webinar SlidedeckMeaningful Use Updates Webinar Slidedeck
Meaningful Use Updates Webinar Slidedeck
 
Health IT Summit Austin 2013 - Keynote Presentation "Meaningful Use Stage 2 a...
Health IT Summit Austin 2013 - Keynote Presentation "Meaningful Use Stage 2 a...Health IT Summit Austin 2013 - Keynote Presentation "Meaningful Use Stage 2 a...
Health IT Summit Austin 2013 - Keynote Presentation "Meaningful Use Stage 2 a...
 
Post analytical variables dr kamlesh patel
Post analytical variables dr kamlesh patelPost analytical variables dr kamlesh patel
Post analytical variables dr kamlesh patel
 
Meaningful use stage 2 - Final Rule
Meaningful use stage 2 - Final RuleMeaningful use stage 2 - Final Rule
Meaningful use stage 2 - Final Rule
 
Q&A về quy định quản lý hệ thống vi tính theo tiêu chuẩn GMP EU
Q&A về quy định quản lý hệ thống vi tính theo tiêu chuẩn GMP EUQ&A về quy định quản lý hệ thống vi tính theo tiêu chuẩn GMP EU
Q&A về quy định quản lý hệ thống vi tính theo tiêu chuẩn GMP EU
 
Calibration of master plan
Calibration of master planCalibration of master plan
Calibration of master plan
 
Hospital erp system
Hospital erp systemHospital erp system
Hospital erp system
 
How to get Prepared and Find Success with Meaningful Use Stage 2 and 3
How to get Prepared and Find Success with Meaningful Use Stage 2 and 3How to get Prepared and Find Success with Meaningful Use Stage 2 and 3
How to get Prepared and Find Success with Meaningful Use Stage 2 and 3
 
MU - PQRS presentation
MU - PQRS  presentationMU - PQRS  presentation
MU - PQRS presentation
 
Quy định về quản lý hệ thống vi tính theo tiêu chuẩn GMP Nhật Bản
Quy định về quản lý hệ thống vi tính theo tiêu chuẩn GMP Nhật BảnQuy định về quản lý hệ thống vi tính theo tiêu chuẩn GMP Nhật Bản
Quy định về quản lý hệ thống vi tính theo tiêu chuẩn GMP Nhật Bản
 
OrHIMA Meaningful Use Stage 2 Presentation
OrHIMA Meaningful Use Stage 2 PresentationOrHIMA Meaningful Use Stage 2 Presentation
OrHIMA Meaningful Use Stage 2 Presentation
 

More from data brackets

Presence Health Resolution Agreement with OCR
Presence Health Resolution Agreement with OCRPresence Health Resolution Agreement with OCR
Presence Health Resolution Agreement with OCR
data brackets
 
Oregon Health & Science University HIPAA Fines
Oregon Health & Science University HIPAA FinesOregon Health & Science University HIPAA Fines
Oregon Health & Science University HIPAA Fines
data brackets
 
Catholic Health Care Services Resolution Agreement
Catholic Health Care Services Resolution Agreement Catholic Health Care Services Resolution Agreement
Catholic Health Care Services Resolution Agreement
data brackets
 
NYP RA and Cap april 2016
NYP RA and Cap april 2016 NYP RA and Cap april 2016
NYP RA and Cap april 2016
data brackets
 
NYP RA and CAP april 2016
NYP RA and CAP april 2016 NYP RA and CAP april 2016
NYP RA and CAP april 2016
data brackets
 
Raleigh Orthopedic RA and CAP April 2016
Raleigh Orthopedic RA and CAP April 2016Raleigh Orthopedic RA and CAP April 2016
Raleigh Orthopedic RA and CAP April 2016
data brackets
 
HIPAA Violation Fines: North memorial Hospistal Settlement
 HIPAA Violation Fines: North memorial Hospistal Settlement  HIPAA Violation Fines: North memorial Hospistal Settlement
HIPAA Violation Fines: North memorial Hospistal Settlement
data brackets
 
Lincare HIPAA remediated decision by administrative judge
Lincare HIPAA remediated decision by administrative judgeLincare HIPAA remediated decision by administrative judge
Lincare HIPAA remediated decision by administrative judge
data brackets
 
Lincare HIPAA Notice of Proposed Determination remediated
Lincare HIPAA Notice of Proposed Determination remediatedLincare HIPAA Notice of Proposed Determination remediated
Lincare HIPAA Notice of Proposed Determination remediated
data brackets
 
Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule and ...
Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule and ...Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule and ...
Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule and ...
data brackets
 
Office of Inspector General Study on OCR's HIPAA audit program
Office of Inspector General Study on OCR's HIPAA audit programOffice of Inspector General Study on OCR's HIPAA audit program
Office of Inspector General Study on OCR's HIPAA audit program
data brackets
 
Cancer Care Group HIPAA Settlement Agreement
Cancer Care Group HIPAA Settlement AgreementCancer Care Group HIPAA Settlement Agreement
Cancer Care Group HIPAA Settlement Agreement
data brackets
 
Parkview HIPAA Settlement - Resolution Agreement
Parkview HIPAA Settlement - Resolution AgreementParkview HIPAA Settlement - Resolution Agreement
Parkview HIPAA Settlement - Resolution Agreement
data brackets
 
HIPAA Settlement New York Presbyterian and Columbia Universtiy
HIPAA Settlement New York Presbyterian and Columbia UniverstiyHIPAA Settlement New York Presbyterian and Columbia Universtiy
HIPAA Settlement New York Presbyterian and Columbia Universtiy
data brackets
 
Qca agreement
Qca agreementQca agreement
Qca agreement
data brackets
 
Concentra agreement
Concentra agreementConcentra agreement
Concentra agreement
data brackets
 
Skagit county- HIPAA violation settlement agreement with HHS
Skagit county- HIPAA violation settlement agreement with HHSSkagit county- HIPAA violation settlement agreement with HHS
Skagit county- HIPAA violation settlement agreement with HHS
data brackets
 
EHR meaningful use security risk assessment sample document
EHR meaningful use security risk assessment sample documentEHR meaningful use security risk assessment sample document
EHR meaningful use security risk assessment sample document
data brackets
 
Adult & Pediatric Dermatology, Corrective Action Plan
Adult & Pediatric Dermatology, Corrective Action PlanAdult & Pediatric Dermatology, Corrective Action Plan
Adult & Pediatric Dermatology, Corrective Action Plan
data brackets
 
Affinity agreement
Affinity agreementAffinity agreement
Affinity agreement
data brackets
 

More from data brackets (20)

Presence Health Resolution Agreement with OCR
Presence Health Resolution Agreement with OCRPresence Health Resolution Agreement with OCR
Presence Health Resolution Agreement with OCR
 
Oregon Health & Science University HIPAA Fines
Oregon Health & Science University HIPAA FinesOregon Health & Science University HIPAA Fines
Oregon Health & Science University HIPAA Fines
 
Catholic Health Care Services Resolution Agreement
Catholic Health Care Services Resolution Agreement Catholic Health Care Services Resolution Agreement
Catholic Health Care Services Resolution Agreement
 
NYP RA and Cap april 2016
NYP RA and Cap april 2016 NYP RA and Cap april 2016
NYP RA and Cap april 2016
 
NYP RA and CAP april 2016
NYP RA and CAP april 2016 NYP RA and CAP april 2016
NYP RA and CAP april 2016
 
Raleigh Orthopedic RA and CAP April 2016
Raleigh Orthopedic RA and CAP April 2016Raleigh Orthopedic RA and CAP April 2016
Raleigh Orthopedic RA and CAP April 2016
 
HIPAA Violation Fines: North memorial Hospistal Settlement
 HIPAA Violation Fines: North memorial Hospistal Settlement  HIPAA Violation Fines: North memorial Hospistal Settlement
HIPAA Violation Fines: North memorial Hospistal Settlement
 
Lincare HIPAA remediated decision by administrative judge
Lincare HIPAA remediated decision by administrative judgeLincare HIPAA remediated decision by administrative judge
Lincare HIPAA remediated decision by administrative judge
 
Lincare HIPAA Notice of Proposed Determination remediated
Lincare HIPAA Notice of Proposed Determination remediatedLincare HIPAA Notice of Proposed Determination remediated
Lincare HIPAA Notice of Proposed Determination remediated
 
Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule and ...
Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule and ...Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule and ...
Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule and ...
 
Office of Inspector General Study on OCR's HIPAA audit program
Office of Inspector General Study on OCR's HIPAA audit programOffice of Inspector General Study on OCR's HIPAA audit program
Office of Inspector General Study on OCR's HIPAA audit program
 
Cancer Care Group HIPAA Settlement Agreement
Cancer Care Group HIPAA Settlement AgreementCancer Care Group HIPAA Settlement Agreement
Cancer Care Group HIPAA Settlement Agreement
 
Parkview HIPAA Settlement - Resolution Agreement
Parkview HIPAA Settlement - Resolution AgreementParkview HIPAA Settlement - Resolution Agreement
Parkview HIPAA Settlement - Resolution Agreement
 
HIPAA Settlement New York Presbyterian and Columbia Universtiy
HIPAA Settlement New York Presbyterian and Columbia UniverstiyHIPAA Settlement New York Presbyterian and Columbia Universtiy
HIPAA Settlement New York Presbyterian and Columbia Universtiy
 
Qca agreement
Qca agreementQca agreement
Qca agreement
 
Concentra agreement
Concentra agreementConcentra agreement
Concentra agreement
 
Skagit county- HIPAA violation settlement agreement with HHS
Skagit county- HIPAA violation settlement agreement with HHSSkagit county- HIPAA violation settlement agreement with HHS
Skagit county- HIPAA violation settlement agreement with HHS
 
EHR meaningful use security risk assessment sample document
EHR meaningful use security risk assessment sample documentEHR meaningful use security risk assessment sample document
EHR meaningful use security risk assessment sample document
 
Adult & Pediatric Dermatology, Corrective Action Plan
Adult & Pediatric Dermatology, Corrective Action PlanAdult & Pediatric Dermatology, Corrective Action Plan
Adult & Pediatric Dermatology, Corrective Action Plan
 
Affinity agreement
Affinity agreementAffinity agreement
Affinity agreement
 

Recently uploaded

❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Fin...
❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Fin...❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Fin...
❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Fin...
❼❷⓿❺❻❷❽❷❼❽ Dpboss Kalyan Satta Matka Guessing Matka Result Main Bazar chart
 
How to Buy an Engagement Ring.pcffbhfbfghfhptx
How to Buy an Engagement Ring.pcffbhfbfghfhptxHow to Buy an Engagement Ring.pcffbhfbfghfhptx
How to Buy an Engagement Ring.pcffbhfbfghfhptx
Charleston Alexander
 
2024-6-01-IMPACTSilver-Corp-Presentation.pdf
2024-6-01-IMPACTSilver-Corp-Presentation.pdf2024-6-01-IMPACTSilver-Corp-Presentation.pdf
2024-6-01-IMPACTSilver-Corp-Presentation.pdf
hartfordclub1
 
Digital Marketing with a Focus on Sustainability
Digital Marketing with a Focus on SustainabilityDigital Marketing with a Focus on Sustainability
Digital Marketing with a Focus on Sustainability
sssourabhsharma
 
Industrial Tech SW: Category Renewal and Creation
Industrial Tech SW:  Category Renewal and CreationIndustrial Tech SW:  Category Renewal and Creation
Industrial Tech SW: Category Renewal and Creation
Christian Dahlen
 
Best practices for project execution and delivery
Best practices for project execution and deliveryBest practices for project execution and delivery
Best practices for project execution and delivery
CLIVE MINCHIN
 
The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...
The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...
The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...
APCO
 
Zodiac Signs and Food Preferences_ What Your Sign Says About Your Taste
Zodiac Signs and Food Preferences_ What Your Sign Says About Your TasteZodiac Signs and Food Preferences_ What Your Sign Says About Your Taste
Zodiac Signs and Food Preferences_ What Your Sign Says About Your Taste
my Pandit
 
Digital Transformation Frameworks: Driving Digital Excellence
Digital Transformation Frameworks: Driving Digital ExcellenceDigital Transformation Frameworks: Driving Digital Excellence
Digital Transformation Frameworks: Driving Digital Excellence
Operational Excellence Consulting
 
Best Competitive Marble Pricing in Dubai - ☎ 9928909666
Best Competitive Marble Pricing in Dubai - ☎ 9928909666Best Competitive Marble Pricing in Dubai - ☎ 9928909666
Best Competitive Marble Pricing in Dubai - ☎ 9928909666
Stone Art Hub
 
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...
IPLTech Electric
 
Presentation by Herman Kienhuis (Curiosity VC) on Investing in AI for ABS Alu...
Presentation by Herman Kienhuis (Curiosity VC) on Investing in AI for ABS Alu...Presentation by Herman Kienhuis (Curiosity VC) on Investing in AI for ABS Alu...
Presentation by Herman Kienhuis (Curiosity VC) on Investing in AI for ABS Alu...
Herman Kienhuis
 
The latest Heat Pump Manual from Newentide
The latest Heat Pump Manual from NewentideThe latest Heat Pump Manual from Newentide
The latest Heat Pump Manual from Newentide
JoeYangGreatMachiner
 
Satta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel Chart
Satta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel ChartSatta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel Chart
Satta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel Chart
➒➌➎➏➑➐➋➑➐➐Dpboss Matka Guessing Satta Matka Kalyan Chart Indian Matka
 
Call8328958814 satta matka Kalyan result satta guessing
Call8328958814 satta matka Kalyan result satta guessingCall8328958814 satta matka Kalyan result satta guessing
Call8328958814 satta matka Kalyan result satta guessing
➑➌➋➑➒➎➑➑➊➍
 
Cover Story - China's Investment Leader - Dr. Alyce SU
Cover Story - China's Investment Leader - Dr. Alyce SUCover Story - China's Investment Leader - Dr. Alyce SU
Cover Story - China's Investment Leader - Dr. Alyce SU
msthrill
 
Unveiling the Dynamic Personalities, Key Dates, and Horoscope Insights: Gemin...
Unveiling the Dynamic Personalities, Key Dates, and Horoscope Insights: Gemin...Unveiling the Dynamic Personalities, Key Dates, and Horoscope Insights: Gemin...
Unveiling the Dynamic Personalities, Key Dates, and Horoscope Insights: Gemin...
my Pandit
 
2022 Vintage Roman Numerals Men Rings
2022 Vintage Roman  Numerals  Men  Rings2022 Vintage Roman  Numerals  Men  Rings
2022 Vintage Roman Numerals Men Rings
aragme
 
list of states and organizations .pdf
list of  states  and  organizations .pdflist of  states  and  organizations .pdf
list of states and organizations .pdf
Rbc Rbcua
 
Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.
Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.
Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.
AnnySerafinaLove
 

Recently uploaded (20)

❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Fin...
❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Fin...❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Fin...
❼❷⓿❺❻❷❽❷❼❽ Dpboss Matka Result Satta Matka Guessing Satta Fix jodi Kalyan Fin...
 
How to Buy an Engagement Ring.pcffbhfbfghfhptx
How to Buy an Engagement Ring.pcffbhfbfghfhptxHow to Buy an Engagement Ring.pcffbhfbfghfhptx
How to Buy an Engagement Ring.pcffbhfbfghfhptx
 
2024-6-01-IMPACTSilver-Corp-Presentation.pdf
2024-6-01-IMPACTSilver-Corp-Presentation.pdf2024-6-01-IMPACTSilver-Corp-Presentation.pdf
2024-6-01-IMPACTSilver-Corp-Presentation.pdf
 
Digital Marketing with a Focus on Sustainability
Digital Marketing with a Focus on SustainabilityDigital Marketing with a Focus on Sustainability
Digital Marketing with a Focus on Sustainability
 
Industrial Tech SW: Category Renewal and Creation
Industrial Tech SW:  Category Renewal and CreationIndustrial Tech SW:  Category Renewal and Creation
Industrial Tech SW: Category Renewal and Creation
 
Best practices for project execution and delivery
Best practices for project execution and deliveryBest practices for project execution and delivery
Best practices for project execution and delivery
 
The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...
The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...
The APCO Geopolitical Radar - Q3 2024 The Global Operating Environment for Bu...
 
Zodiac Signs and Food Preferences_ What Your Sign Says About Your Taste
Zodiac Signs and Food Preferences_ What Your Sign Says About Your TasteZodiac Signs and Food Preferences_ What Your Sign Says About Your Taste
Zodiac Signs and Food Preferences_ What Your Sign Says About Your Taste
 
Digital Transformation Frameworks: Driving Digital Excellence
Digital Transformation Frameworks: Driving Digital ExcellenceDigital Transformation Frameworks: Driving Digital Excellence
Digital Transformation Frameworks: Driving Digital Excellence
 
Best Competitive Marble Pricing in Dubai - ☎ 9928909666
Best Competitive Marble Pricing in Dubai - ☎ 9928909666Best Competitive Marble Pricing in Dubai - ☎ 9928909666
Best Competitive Marble Pricing in Dubai - ☎ 9928909666
 
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...
Sustainable Logistics for Cost Reduction_ IPLTech Electric's Eco-Friendly Tra...
 
Presentation by Herman Kienhuis (Curiosity VC) on Investing in AI for ABS Alu...
Presentation by Herman Kienhuis (Curiosity VC) on Investing in AI for ABS Alu...Presentation by Herman Kienhuis (Curiosity VC) on Investing in AI for ABS Alu...
Presentation by Herman Kienhuis (Curiosity VC) on Investing in AI for ABS Alu...
 
The latest Heat Pump Manual from Newentide
The latest Heat Pump Manual from NewentideThe latest Heat Pump Manual from Newentide
The latest Heat Pump Manual from Newentide
 
Satta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel Chart
Satta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel ChartSatta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel Chart
Satta Matka Dpboss Matka Guessing Kalyan Chart Indian Matka Kalyan panel Chart
 
Call8328958814 satta matka Kalyan result satta guessing
Call8328958814 satta matka Kalyan result satta guessingCall8328958814 satta matka Kalyan result satta guessing
Call8328958814 satta matka Kalyan result satta guessing
 
Cover Story - China's Investment Leader - Dr. Alyce SU
Cover Story - China's Investment Leader - Dr. Alyce SUCover Story - China's Investment Leader - Dr. Alyce SU
Cover Story - China's Investment Leader - Dr. Alyce SU
 
Unveiling the Dynamic Personalities, Key Dates, and Horoscope Insights: Gemin...
Unveiling the Dynamic Personalities, Key Dates, and Horoscope Insights: Gemin...Unveiling the Dynamic Personalities, Key Dates, and Horoscope Insights: Gemin...
Unveiling the Dynamic Personalities, Key Dates, and Horoscope Insights: Gemin...
 
2022 Vintage Roman Numerals Men Rings
2022 Vintage Roman  Numerals  Men  Rings2022 Vintage Roman  Numerals  Men  Rings
2022 Vintage Roman Numerals Men Rings
 
list of states and organizations .pdf
list of  states  and  organizations .pdflist of  states  and  organizations .pdf
list of states and organizations .pdf
 
Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.
Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.
Anny Serafina Love - Letter of Recommendation by Kellen Harkins, MS.
 

Prepayment Audit Suggested Documentation

  • 1. Page 1 Measure Suggested Documentation Suggested Documentation For Exclusions EPOM 01 Protect Patient Health Information A security risk analysis of the EP's Certified Electronic Health Record Technology (CEHRT) system, which was performed no earlier than the start of the reporting year and no later than the date of attestation (i.e. a report which documents the procedures performed during the analysis and the results of the analysis). This analysis must be in accordance with the requirements under 45 CFR 164.308(a) (1), including addressing the encryption/security of data stored in CEHRT in accordance with requirements under 45 CFR 164.312 (a)(2)(iv) and 45 CFR 164.306(d)(3). The testing could occur prior to the beginning of the first EHR reporting period. However, a new review would have to occur for each subsequent reporting period. Documentation should also be supplied to show that the EP implemented security updates as necessary and corrected identified security deficiencies. There is no exclusion for this measure. EPOM 02 Clinical Decision Support For Measure #1- Documentation which proves that five clinical decision support interventions exist in the EP's CEHRT system (i.e. audit trail, screenshots from the system, letter/e-mail from the vendor, etc.) and that they remained active throughout the EP's reporting period (i.e. a schedule of alerts related to clinical decision support interventions that fired during the reporting period or an indication that the interventions can not be turned off). For Alternate Measure #1 - Documentation which proves that a clinical decision support rule exists in the EP's CEHRT system (i.e. audit trail, screenshots from the system, letter/e-mail from the vendor, etc.) and that it remained active throughout the EP's reporting period (i.e. a schedule of alerts related to a clinical decision support rule that fired during the reporting period or an indication that the rule can not be turned off). For Measure #2- Documentation which proves that this functionality is available in the EP's EHR system (i.e. audit trail, screenshots from the system, letter/e-mail from the vendor, etc.) and that it remained active throughout the EP's reporting period (i.e. a schedule of alerts that fired during the reporting period or an indication that the feature can not be turned off). There is no exclusion for the first measure. To meet the exclusion for the second measure, the EP is required to write fewer than 100 medication orders during the EHR reporting period. To support this exclusion, provide the following: A summary report, preferably generated by the EP's Certified Electronic Health Record Technology system. This report should include the following: ● Denominator for Objective Measure #3 (Medication) which should be < 100 ● Time period which it covers ● Name of the EP EPOM 03 CPOE for Medication, Laboratory, and Radiology Orders A summary report, preferably generated by the EP's Certified Electronic Health Record Technology (CEHRT) system. This report should include the following: ● Numerators and denominators for all three CPOEs ● Time period which it covers (must cover the attestation period) ● Name of the EP If possible, evidence demonstrating that this report was generated by the CEHRT system (i.e. a screenshot of the report before it has been printed from the system). A summary report, preferably generated by the EP's Certified Electronic Health Record Technology system. This report should include the following: ● Denominators for this measure, which should be < 100 (should be 3 sets of numerators & denominators: Medication, Laboratory, Radiology) ● Time period which it covers (must cover the attestation period) ● Name of the EP Note- These exclusions are independent of each other. For example, an EP can be excluded from the medication order measure, but be required to report the laboratory and radiology order measures, based on the threshold of writing 100 orders. Alternate Exclusion for Measure 2 : Providers scheduled to be in Stage 1 in 2015 may claim an exclusion for measure 2 (laboratory orders) of the Stage 2 CPOE objective for an EHR reporting period in 2015. Alternate Exclusion for Measure 3 : Providers scheduled to be in Stage 1 in 2015 may claim an exclusion for measure 3 (radiology orders) of the Stage 2 CPOE objective for an EHR reporting period in 2015. Eligible Professionals- Objective Measures
  • 2. Page 2 Measure Suggested Documentation Suggested Documentation For Exclusions Eligible Professionals- Objective Measures EPOM 04 Electronic Prescribing (eRx) A summary report, preferably generated by the EP's Certified Electronic Health Record Technology (CEHRT) system. This report should include the following: ● Numerator and denominator for this measure ● Time period which it covers (must cover the attestation period) ● Name of the EP If possible, evidence demonstrating that this report was generated by the CEHRT system (i.e. a screenshot of the report before it has been printed from the system). One of the following exclusions must be documented: Exclusion #1A- A summary report, preferably generated by the EP's CEHRT system. This report should include the following: ● Denominator, which must be < 100 ● Time period which it covers (must cover the attestation period) ● Name of the EP Exclusion #1B- A statement indicating that at the start of the EHR reporting period, the EP did not have a pharmacy within their organization or within 10 miles of their practice that accepted electronic prescriptions. EPOM 05 Health Information Exchange A summary report, preferably generated by the EP's Certified Electronic Health Record Technology (CEHRT) system. This report should include the following: ● Numerator and denominator for this measure ● Time period which it covers (must cover the attestation period) ● Name of the EP If possible, evidence demonstrating that this report was generated by the CEHRT system (i.e. a screenshot of the report before it has been printed from the system). A summary report, preferably generated by the EP's Certified Electronic Health Record Technology system. This report should include the following: ● Denominator for this measure which should be < 100 ● Time period which it covers ● Name of the EP Alternate Exclusion : Providers may claim an exclusion for the Stage 2 measure that requires the electronic transmission of a summary of care document if for an EHR reporting period in 2015, they were scheduled to demonstrate Stage 1, which does not have an equivalent measure. EPOM 06 Patient-Specific Education A summary report, preferably generated by the EP's Certified Electronic Health Record Technology (CEHRT) system. This report should include the following: ● Numerator and denominator for this measure ● Time period which it covers (must cover the attestation period) ● Name of the EP If possible, evidence demonstrating that this report was generated by the CEHRT system (i.e. a screenshot of the report before it has been printed from the system). A summary report, preferably generated by the EP's Certified Electronic Health Record Technology system. This report should include the following: ● Denominator for this measure which should be zero ● Time period which it covers (must cover the attestation period) ● Name of the EP Alternate Exclusion : Provider may claim an exclusion for the measure of the Stage 2 Patient Specific Education objective if for an EHR reporting period in 2015 they were scheduled to demonstrate Stage 1 but did not intend to select the Stage 1 Patient Specific Education menu objective. EPOM 07 Medication Reconciliation A summary report, preferably generated by the EP's Certified Electronic Health Record Technology (CEHRT) system. This report should include the following: ● Numerator and denominator for this measure ● Time period which it covers (must cover the attestation period) ● Name of the EP If possible, evidence demonstrating that this report was generated by the CEHRT system (i.e. a screenshot of the report before it has been printed from the system). A summary report, preferably generated by the EP's Certified Electronic Health Record Technology system. This report should include the following: ● Denominator for this measure which should be zero ● Time period which it covers (must cover the attestation period) ● Name of the EP Alternate Exclusion : Provider may claim an exclusion for the measure of the Stage 2 Medication Reconciliation objective if for an EHR reporting period in 2015 they were scheduled to demonstrate Stage 1 but did not intend to select the Stage 1 Medication Reconciliation menu objective.
  • 3. Page 3 Measure Suggested Documentation Suggested Documentation For Exclusions Eligible Professionals- Objective Measures EPOM 08 Patient Electronic Access A summary report, preferably generated by the EP's Certified Electronic Health Record Technology (CEHRT) system. This report should include the following: ● Numerator and denominator for this measure (for both measure #1 & 2) ● Time period which it covers (must cover the attestation period) ● Name of the EP If possible, evidence demonstrating that this report was generated by the CEHRT system (i.e. a screenshot of the report before it has been printed from the system). There is no exclusion for the first measure. Exclusions for the second measure: Exclusion #1A- A statement indicating why the EP does not order or create any of the information listed for inclusion as part of the measure (patient name, provider's name and office contact information, current and past problem list, procedures, laboratory test results, current medication list and medication history, current medication allergy list and medication allergy history, vital signs, smoking status, demographic information, care plan fields, and any known care team members including the primary care provider (PCP) of record) except for "Patient name" and "Provider's name and office contact information". (Excludes second measure only) Exclusion #1B- A statement identifying the county and zip code where the EP conducts ≥ 50% of his/her patient encounters. (Excludes second measure only) Alternate Exclusion Measure #2- Providers may claim an exclusion for the second measure if for an EHR reporting period in 2015 they were scheduled to demonstrate Stage 1, which does not have an equivalent measure. EPOM 09 Secure Electronic Messaging Documentation which proves that this capability was fully enabled in the EP's EHR system (i.e. audit trail, screenshots from the system, letter/e-mail from the vendor, etc.) and that it remained active throughout the EP's reporting period (i.e. a schedule of alerts that fired during the reporting period or an indication that the feature can not be turned off). One of the following exclusions must be documented: Exclusion #1A- A summary report, generated by the EP's Certified Electronic Health Record Technology system. This report should include the following: ● Denominator for Measure #6 (Patient-Specific Education) which should be zero ● Time period which it covers (must cover the attestation period) ● Name of the EP Exclusion #1B- A statement identifying the county and zip code where the EP conducts ≥ 50% of his/her patient encounters. Alternate Exclusion- An EP may claim an exclusion for the measure if for an EHR reporting period in 2015 they were scheduled to demonstrate Stage 1, which does not have an equivalent measure.
  • 4. Page 4 Measure Suggested Documentation Suggested Documentation For Exclusions Eligible Professionals- Objective Measures EPOM 10 Public Health Reporting One of the following criteria must be documented for each attested to measure: For Active Engagement Option (1), documentation from the EP's public health agency (letter, e- mail, website screenshot, etc.) demonstrating the EP registered to submit data with the PHA or, where applicable, the CDR to which the information is being submitted; registration was completed within 60 days after the start of the EHR reporting period; and the EP is awaiting an invitation from the PHA or CDR to begin testing and validation. An example of acceptable documentation would be a letter or e-mail from the public health agency confirming the date the EP registered to submit data with the PHA or, where applicable, the CDR to which the information is being submitted and that the EP is awaiting an invitation from the PHA or CDR to begin testing and validation. For Active Engagement Option (2), documentation from the EP's public health agency (letter, e- mail, website screenshot, etc.) demonstrating that the EP is in the process of testing and validation of the electronic submission of data. Providers must respond to requests from the PHA or, where applicable, the CDR within 30 days; failure to respond twice within an EHR reporting period would result in that provider not meeting the measure. An example of acceptable documentation would be a letter or e-mail from the public health agency confirming that the EP is in the process of testing and validation of the electronic submission of data. For Active Engagement Option (3), documentation from the EP's public health agency (letter, e- mail, website screenshot, etc.) demonstrating that the EP has completed testing and validation of the electronic submission and is electronically submitting production data to the PHA or CDR. An example of acceptable documentation would be a letter or e-mail from the public health agency confirming that the EP has completed testing and validation of the electronic submission and is electronically submitting production data to the PHA or CDR. One of the following exclusions must be documented: Exclusion #1- Measure #1 - A statement from the EP detailing what types of immunizations, if any, they administered during the reporting period. If the EP administers immunizations that are not being collected by the registry, obtain confirmation from the registry. Measure #2 - A statement from the EP indicating why they are not in a category of providers that collects ambulatory syndromic surveillance information. Measure #3 - A statement from the EP explaining why they do not diagnose or directly treat any disease associated with a specialized registry or the public health agencies in their jurisdiction. Exclusion #2- Measure #1 - Documentation from the EP's immunization registry or immunization information system (letter, e-mail, website screenshot, etc.) stating that they were not capable of accepting the specific standards required to meet the CEHRT definition at the start of the EHR reporting period. Measure #2 - Documentation from the EP's public health agency (letter, e-mail, website screenshot, etc.) stating that they were not capable of receiving electronic syndromic surveillance data from EPs in the specific standards required to meet the CEHRT definition at the start of the EHR reporting period. Measure #3 - Documentation from the EP's specialized registry (letter, e-mail, website screenshot, etc.) stating that they were not capable of accepting electronic registry transactions in the specific standards required to meet the CEHRT definition at the start of the EHR reporting period. Exclusion #3- Measure #1 - Documentation from the EP's immunization registry or immunization information system (letter, e-mail, website screenshot, etc.) which demonstrates that EP operates in a jurisdiction where no immunization registry or immunization information system has declared readiness to receive immunization data from the EP at the start of the EHR reporting period. Measure #2 - Documentation from the EP's public health agency (letter, e-mail, website screenshot, etc.) which demonstrates that EP operates in a jurisdiction where no public health agency has declared readiness to receive syndromic surveillance data from EPs at the start of the EHR reporting period. Measure #3 - Documentation from the EP's specialized registry (letter, e-mail, website screenshot, etc.) which demonstrates that EP operates in a jurisdiction where no specialized registry for which the EP is eligible has declared readiness to receive electronic registry transactions at the beginning of the EHR reporting period. Alternate Exclusion - EPs scheduled to be in Stage 1 must attest to at least 1 measure from the Public Health Reporting Objective Measures 1-3. • May claim an Alternate Exclusion for Measure 1, Measure 2, or Measure 3. • An Alternate Exclusion may only be claimed for up to two measures, then the provider must either attest to or meet the exclusion requirements for the remaining measure described in 495.22 (e)(10)(i).